Ultragenyx bags first gene therapy approval as previously rejected Sanfilippo asset awaits decision

Ultragenyx wins first gene therapy approval with Genglycos for glycogen storage disease

The FDA approved Ultragenyx's Genglycos gene therapy for a rare glycogen storage disease, marking the company's first gene therapy clearance and providing a priority review voucher.